Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 35

The DOI matches its Crossref record.

Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis

Gülpınar, Ömer, Esen, Barış, Kayış, Aytaç, Gökçe, Mehmet İlker, Süer, Evren · 2018 · Neurourology and Urodynamics

Abstract

Introduction: Intravesical glucosaminoglycan (GAG) replacement therapies are commonly used in the treatment of bladder pain syndrome (BPS)/interstitial cystitis (IC). Different intravesical glucosaminoglycan products are currently available. In this prospective study, clinical efficacy of chondroitin sulfate and hyaluronic acid are compared in patients with BPS/IC. Methods: Patients were randomized to CS and HA groups. All patients were evaluated for visual analogue pain scale (VAS), interstitial cystitis symptom index (ICSI), interstitial cystitis problem index (ICPI), voiding diary for frequency/nocturia, and mean urine volume per void at the beginning of the therapy and after 6 months. All patients had a potassium sensitivity test (PST) initially. Wilcoxon and Mann‐Whitney U tests were used for statistical analysis. Results: There were 21 patients in both groups. Mean age of patients in CS and HA groups were 47.10 and 48.90, respectively(P > 0.05). Before treatment, Parson's test was positive in 64.3% of patients (27/42) with no difference between groups. VAS of pain, ICSI, ICPI, frequency at 24 h and nocturia results have improved significantly at both treatment arms. Intravesical CS was also found superior to intravesical HA in terms of 24 h frequency, nocturia and ICPI (P < 0.05). No severe adverse effects were reported. Conclusions: Data comparing clinical efficiencies of different GAG therapies are very limited. In this study, intravesical CS was found superior to intravesical HA in terms of 24 h frequency, nocturia and ICPI in patients with BPS/IC in short term follow‐up. To provide a definitive conclusion on superiority of one GAG therapy to others, further evaluation with long term follow up is required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/nau.23284

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. 10.1016/j.juro.2011.03.132 · DOI · Paper page
  2. 10.1016/j.juro.2011.10.040 · DOI
  3. 10.1007/BF00182044 · doi:10.1007/bf00182044
  4. 10.1016/j.tjog.2014.09.007 · doi:10.1016/j.tjog.2014.09.007
  5. 10.1016/j.eururo.2013.04.035 · DOI · Paper page
  6. 10.1016/S0022-5347(17)38437-9 · DOI · Paper page
  7. 10.1016/S0022-5347(01)65933-0 · doi:10.1016/s0022-5347(01)65933-0
  8. 10.1111/j.1464-410X.2005.05776.x · doi:10.1111/j.1464-410x.2005.05776.x
  9. 10.1080/00365590410015876-1 · DOI
  10. 10.1007/s00192-007-0515-5 · doi:10.1007/s00192-007-0515-5
  11. Hanno P, 2005, Incontinence, 1456
  12. 10.1016/S0090-4295(96)00322-6 · doi:10.1016/s0090-4295(96)00322-6
  13. Steinhoff G, 2002, The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis, Can J Urol, 9, 1454
  14. 10.1111/j.1464-410X.2008.08028.x · doi:10.1111/j.1464-410x.2008.08028.x
  15. 10.1016/j.urology.2010.03.016 · DOI
  16. 10.1016/j.urology.2012.01.059 · DOI
  17. 10.1007/s00192-011-1546-5 · doi:10.1007/s00192-011-1546-5
  18. 10.1007/s00192-012-1742-y · doi:10.1007/s00192-012-1742-y
  19. 10.1177/1756287213490052 · DOI
  20. 10.5489/cuaj.2036 · doi:10.5489/cuaj.2036
  21. 10.1016/S0022-5347(17)32495-3 · doi:10.1016/s0022-5347(17)32495-3
  22. 10.1007/s00192-015-2890-7 · doi:10.1007/s00192-015-2890-7

Cited by

Metadata

Authors
Gülpınar, Ö., Esen, B., Kayış, A., Gökçe, M. İ., & Süer, E.
Affiliations
  • Department of Urology Ankara University Ankara Turkey
  • Department of Urology Kars State Hospital Kars Turkey
Venue
Neurourology and Urodynamics
Publisher
Wiley
Published
2017-05-08
Volume
37
Issue
1
Pages
257-262
ISSN
  • 0733-2467
  • 1520-6777
Cited by
35
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.